Since December 2019, a severe acute respiratory infection (SARI) caused by 2019 novel
coronavirus (SARS-CoV-2), began to spread from Wuhan to all of China [1, 2], and indeed the …

The outbreak of coronavirus disease 2019 (COVID-19) has been very severe in China. 1 As
of March 2020, many tens of thousands of patients have had confirmed COVID-19, and …

Introduction With intense deficiency of medical resources during COVID-19 pandemic, risk
stratification is of strategic importance. Blood glucose level is an important risk factor for the …

Background Nirmatrelvir plus ritonavir (Paxlovid) reduced the risk of hospitalization or death
by 89% in high-risk, ambulatory adults with COVID-19. We aimed at studying the efficacy …

Ischemia and reperfusion injury ( IRI ) is an inevitable event in conventional organ
transplant procedure and is associated with significant mortality and morbidity post‐transplantation. …

Introduction Severe sepsis is associated with a high mortality rate despite implementation of
guideline recommendations. Adjunctive treatment may be efficient and require further …

Objectives To describe the epidemiology, microbiology and management of invasive Candida
infection (ICI) in intensive care units (ICUs) in China. Methods A multicentre, prospective, …

The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug-resistant, …

Background There are no effective therapies for patients with Coronavirus disease-2019 (COVID-19).
Methods Forty-one patients with confirmed COVID-19 were enrolled in the study …

Background & Aims Ischemia-reperfusion injury (IRI) has thus far been considered as an
inevitable component of organ transplantation, compromising outcomes, and limiting organ …